Barclays’s BioXcel Therapeutics BTAI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Sell |
8
-1,902
| -100% | – | ﹤0.01% | 4357 |
|
|
2025
Q1 | $4K | Buy |
1,910
+1,822
| +2,070% | +$3.82K | ﹤0.01% | 4219 |
|
|
2024
Q4 | $0 | Hold |
88
| – | – | ﹤0.01% | 4364 |
|
|
2024
Q3 | $0 | Sell |
88
-49
| -36% | – | ﹤0.01% | 4328 |
|
|
2024
Q2 | $0 | Sell |
137
-14,635
| -99% | – | ﹤0.01% | 4189 |
|
|
2024
Q1 | $41K | Sell |
14,772
-13,123
| -47% | -$36.4K | ﹤0.01% | 3854 |
|
|
2023
Q4 | $82K | Buy |
27,895
+20,239
| +264% | +$59.5K | ﹤0.01% | 3755 |
|
|
2023
Q3 | $18K | Sell |
7,656
-93,064
| -92% | -$219K | ﹤0.01% | 3921 |
|
|
2023
Q2 | $671K | Buy |
100,720
+44,697
| +80% | +$298K | ﹤0.01% | 2414 |
|
|
2023
Q1 | $1.05M | Buy |
56,023
+50,887
| +991% | +$949K | ﹤0.01% | 2107 |
|
|
2022
Q4 | $111K | Buy |
5,136
+4,325
| +533% | +$93.5K | ﹤0.01% | 3401 |
|
|
2022
Q3 | $10K | Sell |
811
-1,626
| -67% | -$20K | ﹤0.01% | 4165 |
|
|
2022
Q2 | $32K | Sell |
2,437
-452
| -16% | -$5.94K | ﹤0.01% | 3909 |
|
|
2022
Q1 | $61K | Sell |
2,889
-18,040
| -86% | -$381K | ﹤0.01% | 3916 |
|
|
2021
Q4 | $426K | Buy |
20,929
+10,588
| +102% | +$216K | ﹤0.01% | 2591 |
|
|
2021
Q3 | $314K | Buy |
10,341
+4,429
| +75% | +$134K | ﹤0.01% | 2793 |
|
|
2021
Q2 | $172K | Buy |
+5,912
| New | +$172K | ﹤0.01% | 2951 |
|
|
2021
Q1 | – | Sell |
-480
| Closed | -$22K | – | 3904 |
|
|
2020
Q4 | $22K | Sell |
480
-28,007
| -98% | -$1.28M | ﹤0.01% | 3366 |
|
|
2020
Q3 | $1.24M | Buy |
28,487
+27,887
| +4,648% | +$1.21M | ﹤0.01% | 1793 |
|
|
2020
Q2 | $32K | Buy |
+600
| New | +$32K | ﹤0.01% | 3497 |
|
|
2020
Q1 | – | Sell |
-6,940
| Closed | -$101K | – | 3662 |
|
|
2019
Q4 | $101K | Buy |
6,940
+3,968
| +134% | +$57.7K | ﹤0.01% | 3441 |
|
|
2019
Q3 | $21K | Sell |
2,972
-914
| -24% | -$6.46K | ﹤0.01% | 3837 |
|
|
2019
Q2 | $43K | Buy |
+3,886
| New | +$43K | ﹤0.01% | 3867 |
|
|
2018
Q2 | – | Sell |
-618,249
| Closed | -$6.33M | – | 4198 |
|
|
2018
Q1 | $6.33M | Buy |
+618,249
| New | +$6.33M | ﹤0.01% | 847 |
|